Interferon alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation

被引:8
|
作者
Wietzke, P
Braun, F
Ringe, B
Ramadori, G
机构
[1] Univ Gottingen, Abt Gastroenterol & Endokrinol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Klin Transplantat Chirurg, D-37075 Gottingen, Germany
关键词
D O I
10.1016/S0041-1345(00)01782-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:2539 / 2542
页数:4
相关论文
共 50 条
  • [41] Transient Visual Loss in a Hepatitis C Patient Treated With Pegylated Interferon Alfa-2a and Ribavirin
    Jancoriene, Ligita
    Norvydaite, Dovile
    Galgauskas, Saulius
    Balciunaite, Evelina
    HEPATITIS MONTHLY, 2014, 14 (02)
  • [42] Durability of Response in Children Treated With Pegylated Interferon alfa-2a ± Ribavirin for Chronic Hepatitis C
    Schwarz, Kathleen B.
    Molleston, Jean P.
    Jonas, Maureen M.
    Wen, Jessica
    Murray, Karen F.
    Rosenthal, Philip
    Gonzalez-Peralta, Regino P.
    Lobritto, Steven J.
    Mogul, Douglas
    Pavlovic, Vedran
    Warne, Charles
    Wat, Cynthia
    Thompson, Bruce
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 62 (01): : 93 - 96
  • [43] Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation
    Lodato, F.
    Berardi, S.
    Gramenzi, A.
    Mazzella, G.
    Lenzi, M.
    Morelli, M. C.
    Tame, M. R.
    Piscaglia, F.
    Andreone, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (04) : 450 - 457
  • [44] Dermatological disorders of the extrahepatic manifistations of hepatitis C and its dependence of antiviral therapy with pegylated interferon alfa-2a and ribavirin
    Palgova, Lk
    Sariyeva, Si
    Palgova, Ga
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A12 - A12
  • [45] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [46] Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials
    Chalasani, N
    Manzarbeitia, C
    Ferenci, P
    Vogel, W
    Fontana, RJ
    Voigt, M
    Riely, C
    Martin, P
    Teperman, L
    Jiao, J
    Lopez-Talavera, JC
    HEPATOLOGY, 2005, 41 (02) : 289 - 298
  • [47] Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-α promoter polymorphism
    Schiemann, U
    Glas, J
    Török, P
    Simperl, C
    Martin, K
    König, A
    Schmidt, F
    Schaefer, M
    Folwaczny, C
    DIGESTION, 2003, 68 (01) : 1 - 4
  • [48] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C REPLY
    Albrecht, Janice
    McHutchison, John
    Sulkowski, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1809 - 1809
  • [49] Remission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation
    Sikaneta, T
    Williams, WW
    Chung, RT
    Cosimi, AB
    Pascual, M
    TRANSPLANTATION, 2002, 74 (12) : 1767 - 1768
  • [50] INTERFERON ALFA-2A THERAPY IN CRYOGLOBULINEMIA ASSOCIATED WITH HEPATITIS-C VIRUS
    MISIANI, R
    BELLAVITA, P
    FENILI, D
    VICARI, O
    MARCHESI, D
    SIRONI, PL
    ZILIO, P
    VERNOCCHI, A
    MASSAZZA, M
    VENDRAMIN, G
    TANZI, E
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (11): : 751 - 756